Targeting Oncoprotein Translation with Rocaglates in MYC-Driven Lymphoma

被引：2
|
作者：
Zhang, Xuan [1 ]
Bi, Chengfeng [1 ]
Lu, Ting [2 ]
Yue, Ting [3 ]
Zhang, Weiwei [1 ]
Zhang, Xiaoyan [4 ]
Cheng, Wang [1 ]
Tian, Tian [1 ]
Lunning, Matthew A. [1 ]
Vose, Julie M. [1 ]
Pelletier, Jerry [5 ]
Porco, John A., Jr. [6 ]
Tao, Jianguo [7 ]
Fu, Kai [1 ]
机构：
[1] Univ Nebraska Med Ctr, Omaha, NE USA
[2] City Hope Natl Med Ctr, Duarte, CA USA
[3] Shanghai Jiao Tong Univ, Sch Med, Shanghai, Peoples R China
[4] China Yixueke Xueyuan Hemopathy Hosp, Tianjin, Peoples R China
[5] McGill Univ, Montreal, PQ, Canada
[6] Boston Univ, Boston, MA 02215 USA
[7] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-117659
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
38
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Targeting translation initiation by synthetic rocaglates for treating MYC-driven lymphomas
    Zhang, Xuan
    Bi, Chengfeng
    Lu, Ting
    Zhang, Weiwei
    Yue, Ting
    Wang, Cheng
    Tian, Tian
    Zhang, Xiaoyan
    Huang, Yuhua
    Lunning, Matthew
    Hao, Xinbao
    Brown, Lauren E.
    Devine, William G.
    Vose, Julie
    Porco, John A., Jr.
    Fu, Kai
    LEUKEMIA, 2020, 34 (01) : 138 - 150
  • [2] Targeting translation initiation by synthetic rocaglates for treating MYC-driven lymphomas
    Xuan Zhang
    Chengfeng Bi
    Ting Lu
    Weiwei Zhang
    Ting Yue
    Cheng Wang
    Tian Tian
    Xiaoyan Zhang
    Yuhua Huang
    Matthew Lunning
    Xinbao Hao
    Lauren E. Brown
    William G. Devine
    Julie Vose
    John A. Porco
    Kai Fu
    Leukemia, 2020, 34 : 138 - 150
  • [3] Targeting MYC-driven translation
    Sarah Crunkhorn
    Nature Reviews Drug Discovery, 2017, 16 (7) : 456 - 456
  • [4] Targeting MYC-driven translation
    不详
    NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (07) : 448 - 448
  • [5] Targeting nucleotide synthesis in MYC-driven lymphoma
    Gemma K. Alderton
    Nature Reviews Cancer, 2014, 14 (7) : 452 - 452
  • [6] Synthetic lethal targeting of SUMOylation in Myc-driven lymphoma
    Hoellein, A.
    Fallahi, M.
    Schaub, F.
    Schoeffmann, S.
    Steidle, S.
    Rudelius, M.
    Miething, C.
    Peschel, C.
    Cleveland, J.
    Keller, U.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 11 - 11
  • [7] Targeting MYC-driven lymphoma: lessons learned and future directions
    Martinez-Martin, Sandra
    Beaulieu, Marie-Eve
    Soucek, Laura
    CANCER DRUG RESISTANCE, 2023, 6 (02) : 205 - 222
  • [8] Enhanced therapy for MYC-driven medulloblastoma by targeting protein translation pathway
    Chaturvedi, Nagendra K.
    Coulter, Don W.
    Kling, Matthew J.
    Ray, Sutapa
    McGuire, Timothy R.
    Joshi, Shantaram S.
    Sharp, J. Graham
    CANCER RESEARCH, 2018, 78 (13)
  • [9] Combination Therapy Targeting Ribosome Biogenesis and mRNA Translation Synergistically Extends Survival in MYC-Driven Lymphoma
    Devlin, Jennifer R.
    Hannan, Katherine M.
    Hein, Nadine
    Cullinane, Carleen
    Kusnadi, Eric
    Ng, Pui Yee
    George, Amee J.
    Shortt, Jake
    Bywater, Megan J.
    Poortinga, Gretchen
    Sanij, Elaine
    Kang, Jian
    Drygin, Denis
    O'Brien, Sean
    Johnstone, Ricky W.
    McArthur, Grant A.
    Hannan, Ross D.
    Pearson, Richard B.
    CANCER DISCOVERY, 2016, 6 (01) : 59 - 70
  • [10] Scribble acts as an oncogene in Eμ-myc-driven lymphoma
    E D Hawkins
    J Oliaro
    K M Ramsbottom
    A Newbold
    P O Humbert
    R W Johnstone
    S M Russell
    Oncogene, 2016, 35 : 1193 - 1197
12345